Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer

MLA

Ulrich Keller, et al. “Combination of Copanlisib with Cetuximab Improves Tumor Response in Cetuximab-Resistant Patient-Derived Xenografts of Head and Neck Cancer.” Oncotarget, vol. 11, no. 41, Oct. 2020, pp. 3688–97. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....84d845b638844f2322a1f8bbde92a6d5&authtype=sso&custid=ns315887.

APA

Ulrich Keller, Andreas E. Albers, Raik Otto, Jan-Dirk Raguse, Jens Hoffmann, Theresa Eder, Konrad Klinghammer, Andreas M. Kaufmann, Ulrich Keilholz, Ingeborg Tinhofer, & Oliver Politz. (2020). Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer. Oncotarget, 11(41), 3688–3697.

Chicago

Ulrich Keller, Andreas E. Albers, Raik Otto, Jan-Dirk Raguse, Jens Hoffmann, Theresa Eder, Konrad Klinghammer, et al. 2020. “Combination of Copanlisib with Cetuximab Improves Tumor Response in Cetuximab-Resistant Patient-Derived Xenografts of Head and Neck Cancer.” Oncotarget 11 (41): 3688–97. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....84d845b638844f2322a1f8bbde92a6d5&authtype=sso&custid=ns315887.